Australia's most trusted
source of pharma news
Tuesday, 28 April 2026
Tuesday, 28 April 2026
Subscribe
Login
Big Pharma goes under the hammer
A new Top 25 pharma will emerge following an AU$16 billion deal, with the new business boasting a footprint in 150 countries with 18 large markets to generate more than US$100M in revenue.
Vax slide a drag on productivity
Pfizer uses pre-budget submission to call on the federal government to increase investment in preventative health
TODAY
PBAC greenlights new drugs
Out of 26 new PBS listing submissions considered by the PBAC in March, a massive 23 were recommended
TODAY
Lilly refuses PBS listing price
After finally winning a PBAC recommendation on its fourth attempt, Lilly will not make this blockbuster available on the PBS
24 April
MD's message to Dept workers
An Australian pharma leader has made a pitch to public servants, laying out the case to change the way medicines are funded
24 April
Long-timers jumping companies
Seasoned pharma professionals from across industry are moving to new companies and new roles in the latest employment shifts
23 April
Aussie pharma naughty or nice?
Analysis of Medicines Australia complaint outcomes over three years reveals how often companies are breaching the Code of Conduct
23 April
Latest Jobs
Trade Marketing ManagerProduct ManagerInternal Communications SpecialistStorepersonSenior Medical ManagerTrade Marketing ManagerSenior Product ManagerTerritory Manager - Surgical24 more...
Pharma in Focus Jobs
Marketing & Communications (8)
- Trade Marketing Manager - Sydney
- Product Manager - New South Wales
- Internal Communications Specialist - Melbourne
- Trade Marketing Manager - Sydney
- Senior Product Manager - Sydney
- Associate Marketing Manager - OTC - Sydney
- Senior Data & Insights Analyst - Melbourne
- Data & Insights Analyst - Melbourne
Sales & Customer Relations (9)
- Territory Manager - Surgical - Sydney
- Pharmaceutical Sales Representative - Sydney
- Account Manager - Sydney
- Senior Territory Manager - Melbourne
- Customer Service Representative - East Ryde
- Customer Service Specialist - Frenchs Forest
- Customer Service Lead - Frenchs Forest
- Customer Service Representative - St Leonards
- Hospital Specialist Representative - Melbourne
Clinical & Medical, R&D (8)
- Senior Medical Manager - Melbourne
- Senior Medical Science Liaison - Melbourne
- Clinical Trial Start Up Specialist - Melbourne
- Clinical Project Manager - Oncology - Sydney, NSW
- Clinical Trials Investigator - Melbourne
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Medical Lead - Sydney
- Pharmacovigilance and Medical Information Associate - Sydney
Regulatory, Pharmacovigilance & QA (3)
- QA Specialist - Melbourne
- Senior Regulatory Affairs Associate - Sydney
- Pharmacovigilance and Medical Information Associate - Sydney
Executive Roles (1)
Other (6)
PBAC pushes biologics to first line
Nine recommendations for new indications plus a 'yes' to paediatric patients with Crohn's to going straight to biologics
TODAY
New ALS treatment approved
Bumper list of medicines join the ARTG, including the first copycat of a PBS listed drug plus multiple brands containing semaglutide
TODAY Approvals Action
Real World Evidence feud goes legal
Bayer and Johnson & Johnson go head-to-head in a US court over survival claims for two big prostate cancer drugs
24 April
Jobs go in company restructure
ICYMI: Another company undergoes 'streamlining' with undisclosed job losses plus other popular stories this week
24 April Your Week in 5 Minutes
PBS a lever for medicine supply?
Geopolitical tensions are exposing the fragility of global supply chains but perhaps the PBS can help reduce Australia's vulnerability
24 April
Boehringer shows its heart
Company steps up to support a program that takes healthcare to rural, regional, and remote areas of Australia
24 April
One of industry's best moves on
Two-time PRIME Awards winner lands a new job outside industry at 'one of the fastest growing companies since Canva'
23 April
Shortage looms on demand surge
Another shortage of this drug is on the horizon, with the TGA renewing a Serious Scarcity Substitution Instrument
23 April
Gene therapy finds footing in Aust
Who's secured a licence to conduct studies of its FDA-approved intravesical gene therapy in Australia?
23 April
Final contender in MA Board race
Voting is now open to fill four vacancies on the Medicines Australia Board with an official count of 10 leaders in the running
22 April
From napkin to buyout in 10 years
An Australian pharma consulting firm with almost 500 market access projects under its belt now has international backing
22 April
J&J chases record-breaking sales
This company has set its sights on an ambitious goal of $100 billion in revenue this year... but analysts aren't so sure
22 April
Oncolytic immunotherapy cleared
CRO wins the go-ahead to conduct a clinical trial in Australia for Akamis Bio's lead drug candidate in rectal cancer
22 April
Another ex-Govt staffer joins MA
Former Chief of Staff to a Cabinet Minister and one-time newsman joins Medicines Australia, to steer Public Affairs and Govt Relations
22 April